Low‑dose THC shown to ease inflammation, protect liver, and boost gut‑brain health without intoxication
TheDigger Intelligence Unit
A new study suggests that very small amounts of THC might help reduce many long-term side effects of HIV treatment without causing a high. In animal studies, low-dose THC reduced inflammation, improved gut bacteria, increased serotonin levels, and reduced harmful cholesterol and bile acids. It also lowered the amount of antiretroviral drugs in the blood while still keeping the virus under control, which could help protect the liver. Researchers believe these findings could lead to new ways to manage ongoing health issues in people with HIV.
Researchers at Texas Biomedical Research Institute found that using very small amounts of THC over a long period may lower inflammation and reduce some harmful effects linked to HIV and antiretroviral therapy (ART).
THC, which stands for tetrahydrocannabinol, is the main active ingredient in cannabis. In this study, scientists used very low doses that did not cause any noticeable effects on the nervous system, such as feeling high.
The researchers observed several potential benefits, including higher serotonin levels and lower inflammation, cholesterol, and harmful bile acids. One key finding was that ART drug levels in the blood were lower, but the virus stayed under control. Since ART drugs can put stress on the liver over time, this drop could be important. The study used animal models similar to people with HIV on ART, and the results were published in Science Advances.
Why Managing HIV Treatment Side Effects Matters
Today’s ART can suppress HIV to levels that can’t be detected. HIV used to be fatal, but now it is a long-term condition people can manage. Still, people living longer with HIV often deal with ongoing health problems from both the virus and long-term medication use.
“People living with HIV experience chronic inflammation, which leads to many co-morbidities such as cardiovascular disease, liver disease, and some neurological diseases,” said Professor Mahesh Mohan, DVM, Ph.D. “Our lab is interested in finding solutions to help address this.”
This study builds on earlier research from Dr. Mohan’s lab, which looked at the medical uses of low-dose THC. Similar THC-based medicines are already approved by the FDA to treat seizures, nausea and vomiting from chemotherapy, and weight loss related to AIDS.
Extensive Analysis Reveals No Negative Effects
For three years, Lakmini Premadasa, Ph.D., a staff scientist in Dr. Mohan’s lab, studied hundreds of metabolites, which are small molecules important for normal body functions. She wanted to see if taking low-dose THC every day with ART affected other parts of the body.
“There were no downsides,” Dr. Premadasa said. “I kept looking because I couldn’t believe it could all be good, but I really could not find any negative impacts.”
Lower Drug Toxicity Without Losing Viral Control
For the study, researchers used two groups of rhesus macaques infected with simian immunodeficiency virus (SIV), which is similar to HIV in humans. Both groups got ART for five months, but only one group also received low-dose THC. The other group got a placebo.
At the end of the study, both groups had undetectable SIV levels. However, the animals that got THC had much lower levels of ART drugs in their blood compared to those who only got ART.
“This was unexpected,” Dr. Premadasa said. “This suggests that THC is helping to metabolize the antiretroviral drugs faster, which is actually much better to protect the liver from toxicity associated with some currently prescribed ART drugs.”
Low-Dose THC and Gut-Brain Health
Another major discovery involved serotonin, a neurotransmitter that plays a key role in mood, sleep, and digestion. Levels of serotonin were substantially higher in the THC-treated group than in the control group.
The changes occurred across several stages of serotonin production, which largely takes place in the gut. Dr. Premadasa identified that these changes occurred at different steps in serotonin production, most of which occur in the gut. Dr. Premadasa found more serotonin-producing cells and higher levels of helpful gut bacteria (L. plantarum) that support serotonin production. She also saw more serotonin receptors, which help send signals from the gut to the brain through the vagus nerve, improving gut-brain communication. including depression, memory loss, brain fog, and perhaps long-COVID symptoms,” Dr. Mohan said. “Reduced serotonin levels are known to disrupt signaling between the gut and brain, so improving those serotonin levels and communication with low-dose cannabinoids could offer a new or complementary treatment approach.”
Other Benefits for Heart and Liver Health
The group that received THC also had a healthier, more balanced gut microbiome, with more good bacteria that help lower cholesterol. Researchers also saw lower levels of secondary bile acids, which can be harmful in large amounts and can cause liver problems like blocked bile ducts, inflammation, scarring, and even end-stage liver disease.
There were also higher levels of metabolites that help break down fatty acids. These changes are linked to less buildup of artery-clogging plaque and better heart health. In the THC group, levels of harmful fatty acids called long-chain acetylcholines went back to normal, while animals that only got ART still had high levels of these fatty acids.
What Comes Next for This Research
Since this study was done in nonhuman primates, more research is needed to see if the same effects happen in people. The results might also be important for other conditions linked to gut inflammation, like irritable bowel syndrome, chronic liver disease, and brain disorders such as Alzheimer’s and Parkinson’s.ases.
The research team is now studying cannabidiol (CBD), a compound that does not cause a high, together with THC, given by mouth or injection, along with ART. They also plan to look at other cannabinoids and plant-based compounds, such as terpenes. The researchers point out that store-bought cannabinoid products may not have the same effects because of differences in dose, formulation, and how the body processes them. People should talk to a healthcare provider before using any cannabinoid-based treatments.